FCGR3A and benign prostatic hyperplasia: FcγRIIIa protein expression was assessed by using immunohistochemical analysis on the tissue microarrays (TMAs) consisting of benign prostate hyperplasia (BPH), adjacent primary PCa and metastatic PCa lesions in lymph nodes, bone marrows, and lungs from patients with primary and metastatic PCa.